Table 1.
Survey details based on modifications.
(Overall 24,732 surveys completed by 6,780 patients after radical prostatectomy).
| Survey Modification Type | Prior to Addition of Injection Q (N=7,076; 29%) |
Addition of Injection Q (N=13,524; 55%) |
Updated Injection Q and Addition of Partner Q (N=4,132; 17%) |
|---|---|---|---|
| Date of Earliest Survey | April 3, 2009 | March 18, 2012 | March 1, 2017 |
| Number of Patients | 2,805 | 4,680 | 2,117 |
| Survey Timepoint after surgery | |||
| 3-6 months | 1,901 (27%) | 4,399 (33%) | 1,262 (31%) |
| 9-15 months | 1,717 (24%) | 3,348 (25%) | 1,098 (27%) |
| 18-24 months | 1,726 (24%) | 2,900 (21%) | 1,040 (25%) |
| 3 years and later | 1,732 (24%) | 2,877 (21%) | 732 (18%) |
| Nerve-sparing Status | |||
| None | 351 (13%) | 575 (12%) | 236 (11%) |
| Unilateral | 439 (16%) | 886 (19%) | 476 (22%) |
| Bilateral | 1974 (70%) | 3113 (67%) | 1366 (65%) |
| Unknown | 41 (1.5%) | 106 (2.3%) | 39 (1.8%) |
| Adjuvant Hormonal Treatment a | 80 (2.9%) | 197 (4.2%) | 94 (4.4%) |
| Unknown | 1 (<0.1%) | 2 (<0.1%) | 1 (<0.1%) |
| Adjuvant Radiation Treatment a | 48 (1.7%) | 94 (2.0%) | 32 (1.5%) |
| Salvage Hormonal Treatment b | 231 | 484 | 221 |
| Unknown | 1 | 2 | 1 |
| Salvage Radiation Treatment b | 323 | 597 | 234 |
a
Adjuvant treatment defined as within 6-months of radical prostatectomy.
b
Percentages not shown for salvage treatment since patients have different amounts of followup.